Next Article in Journal
Monitoring the Spatiotemporal Activities of miRNAs in Small Animal Models Using Molecular Imaging Modalities
Next Article in Special Issue
Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach
Previous Article in Journal
Secretion of Human Protein C in Mouse Milk
Previous Article in Special Issue
Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(3), 4918-4946;

Cancer Stratification by Molecular Imaging

Heidelberg University Hospital, Department of Nuclear Medicine, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
Author to whom correspondence should be addressed.
Academic Editor: William Chi-Shing Cho
Received: 15 October 2014 / Revised: 13 February 2015 / Accepted: 17 February 2015 / Published: 4 March 2015
Full-Text   |   PDF [1745 KB, uploaded 4 March 2015]   |  


The lack of specificity of traditional cytotoxic drugs has triggered the development of anticancer agents that selectively address specific molecular targets. An intrinsic property of these specialized drugs is their limited applicability for specific patient subgroups. Consequently, the generation of information about tumor characteristics is the key to exploit the potential of these drugs. Currently, cancer stratification relies on three approaches: Gene expression analysis and cancer proteomics, immunohistochemistry and molecular imaging. In order to enable the precise localization of functionally expressed targets, molecular imaging combines highly selective biomarkers and intense signal sources. Thus, cancer stratification and localization are performed simultaneously. Many cancer types are characterized by altered receptor expression, such as somatostatin receptors, folate receptors or Her2 (human epidermal growth factor receptor 2). Similar correlations are also known for a multitude of transporters, such as glucose transporters, amino acid transporters or hNIS (human sodium iodide symporter), as well as cell specific proteins, such as the prostate specific membrane antigen, integrins, and CD20. This review provides a comprehensive description of the methods, targets and agents used in molecular imaging, to outline their application for cancer stratification. Emphasis is placed on radiotracers which are used to identify altered expression patterns of cancer associated markers. View Full-Text
Keywords: cancer stratification; molecular imaging; radiotracers; positron emission tomography (PET); single photon emission computed tomography (SPECT); biomarkers; target structure cancer stratification; molecular imaging; radiotracers; positron emission tomography (PET); single photon emission computed tomography (SPECT); biomarkers; target structure

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Weber, J.; Haberkorn, U.; Mier, W. Cancer Stratification by Molecular Imaging. Int. J. Mol. Sci. 2015, 16, 4918-4946.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top